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After publication of the original article [1], the author
noticed some errors to the article [1] which are included
in this erratum. All errors reported in this erratum have
been updated in the original article [1].
In the ‘Results’ section of the article Abstract, the
sentence “Entropy was associated with a decreased risk of
breast cancer” should be "Entropy was associated with an
increased risk of breast cancer”. In the same section, the
variables "FD_TH10", "FD_TH15", "FD_TH60", "FD_TH85",
"FD_TH75", and "FD_TH75" should include an additional
underscore so they are presented as: "FD_TH_10",
"FD_TH_15", "FD_TH_60", "FD_TH_85", "FD_TH_75", and
"FD_TH_75", respectively. All variables should be italicized.
In the section entitled ‘Breast texture measurements’,
the sentence “the image with only constant grayscale
pixels has Energy equal to 0" should state "the image with
only constant grayscale pixels has Energy equal to 1".
In the ‘Results’ section of the article [1], the variable
“FD_TH_75” included in sentence: “The top left and
bottom left images show a top 20th percent tile value of
FD_TH_75” should be included in italics.
In the ‘Abbreviations’ section, “BGTDM” should be
"NGTDM". The correct version of the ‘Abbreviations’ is
included in this erratum and has been updated in the
original article [1].
In Table 1, in the column “Texture feature name”, the
names of variables should be in italics. In addition in
Table 5, in the column “Feature”, all variables should
also be included in italics. The revised versions of
Tables 1 and 5 are included in this erratum and have
been updated in the original article [1].* Correspondence: serghei.malkov@ucsf.edu
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Table 1 Image texture features that are currently defined for all study participants
Analysis Groups Texture Features Texture feature name Reference










GLCM Mean GLCM Mean
GLCM Variance GLCM Variance
Neighborhood Gray-tone Difference Matrix (NGTDM) NGTDM Coarseness NGTDM Coarseness [24, 28, 29]




Edge Frequency Analysis Mean Gradient Mean_Gradient [29]
Fourier Transform Analysis, Power Spectrum RMS FT_RMS [29]
FMP (first moment of power spectrum) FT_FMP
SMP (second moment of power spectrum) FT_SMP
FD from power spectrum exponent FT_FD
Fractal Analysis Intercept of the plot of the standard deviation of the high
frequency image as a function of the size the kernel
CD_Yint [29–31]
Continuous Dimension (CD), slope and intercept CD_Slope
HZ_PROJ HZ_PROJ
FD of the standard deviation FD_Sigma
FD of image using thresholds from 5%-85% FD_TH_5: FD_TH_85
FD of the surface of thebreast considering the gray
value represent the height
FD_CALDWELL
FD, Minkowski method FD_Minkowski
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Table 5 Risk associated of either DCIS or Invasive Cancer for each feature
Feature DCIS Invasive ER- ER+
OR (95% CI) OR (95% CI) p-value* p-het** OR (95% CI) OR (95% CI) p-value * p-het**
N case/control 254/1659 908/1659 116/1291 746/1291
FD_TH_75 0.87 (0.74, 1.01) 0.87 (0.78, 0.96) 0.010 0.98 0.84 (0.67, 1.06) 0.88 (0.79, 0.99) 0.048 0.72
Energy 0.88 (0.76, 1.02) 0.88 (0.80, 0.96) 0.011 0.93 0.85 (0.69, 1.05) 0.86 (0.78, 0.95) 0.009 0.90
Entropy 1.18 (1.02, 1.38) 1.13 (1.03, 1.25) 0.010 0.60 1.16 (0.93, 1.44) 1.15 (1.03, 1.28) 0.024 0.96
FD_TH_70 0.85 (0.72, 1.00) 0.87 (0.79, 0.97) 0.015 0.75 0.84 (0.67, 1.06) 0.89 (0.79, 1.00) 0.085 0.64
FD_TH_80 0.90 (0.77, 1.04) 0.89 (0.81, 0.98) 0.034 0.90 0.85 (0.68, 1.05) 0.89 (0.80, 1.00) 0.066 0.64
FD_TH_10 1.19 (1.04, 1.38) 1.09 (0.99, 1.19) 0.022 0.21 1.03 (0.84, 1.26) 1.06 (0.96, 1.18) 0.479 0.75
Kurtosis 0.86 (0.73, 1.00) 0.90 (0.81, 0.99) 0.032 0.58 0.98 (0.78, 1.22) 0.91 (0.81, 1.01) 0.216 0.53
FD_TH_65 0.84 (0.71, 0.99) 0.89 (0.80, 0.99) 0.035 0.49 0.83 (0.65, 1.06) 0.91 (0.81, 1.03) 0.170 0.46
FD_Minkowski 0.90 (0.74, 1.08) 0.86 (0.77, 0.97) 0.042 0.71 0.77 (0.59, 1.01) 0.89 (0.78, 1.01) 0.063 0.32
Busyness 1.15 (1.00, 1.33) 1.09 (1.00, 1.19) 0.053 0.46 0.92 (0.75, 1.14) 1.09 (0.99, 1.21) 0.128 0.12
Homogeneity 1.05 (0.90, 1.22) 1.13 (1.03, 1.24) 0.042 0.36 1.06 (0.86, 1.31) 1.12 (1.01, 1.24) 0.091 0.62
Dissimilarity 0.96 (0.83, 1.12) 0.89 (0.81, 0.98) 0.057 0.35 0.95 (0.77, 1.17) 0.89 (0.81, 0.99) 0.110 0.61
FD_TH_60 0.85 (0.71, 1.02) 0.9 (0.8, 1.01) 0.077 0.56 0.9 (0.69, 1.15) 0.92 (0.81, 1.04) 0.348 0.85
FD_TH_85 0.92 (0.79, 1.06) 0.91 (0.83, 1) 0.130 0.98 0.89 (0.72, 1.09) 0.91 (0.82, 1.01) 0.173 0.77
FD_TH_15 1.2 (1.04, 1.39) 1.06 (0.97, 1.16) 0.034 0.09 0.96 (0.78, 1.18) 1.05 (0.95, 1.16) 0.572 0.43
Results presented as OR per 1 SD in normalized feature after adjustment for age, family history, PD, and study
*p-value refers to 2 degree of freedom to test for evidence of associated with DCIS or invasive cancer
**Heterogeneity p-value to test for differences in effect between tumor subgroups
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